Radioiodine-induced changes in lymphocyte subsets in patients with differentiated thyroid carcinoma

European Journal of Nuclear Medicine

Volumn 26, Issue 8, 1999, Pages 824-829

  Tofani, Anna ^a   Sciuto, Rosa ^a   Cioffi, Raffaele P ^a   Pasqualoni, Rosella ^a   Rea, Sandra ^a   Festa, Anna ^a   Gandolfo, Giuseppe M ^a   Arista, Maria C ^a   Maini, Carlo L ^a,b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b NONE   (Italy)

Author keywords

Lymphocyte subsets; Radioiodine; Thyroid cancer

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; IODINE 131; LEVOTHYROXINE; LIOTHYRONINE; MICROSOME ANTIBODY; RADIOACTIVE IODINE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HELPER CELL; HUMAN; HYPOTHYROIDISM; IMMUNE DEFICIENCY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; RADIOSENSITIVITY; T LYMPHOCYTE; THYROID CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; ADULT; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; THYROID NEOPLASMS; TIME FACTORS;

EID: 0032799510     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050455     Document Type: Article

References (32)

1. 1. Blombreg H, Edsmyr F, Naslund I, Petrini B, Wassermann J. Distribution of lymphocyte subsets following radiation therapy directed to different body regions. Clin Oncol 1983; 9: 289-298.
2. 2. Idestrom K, Petrini B, Blomgren H, Wasserman J, Wallengren A, Baral E. Changes of peripheral lymphocyte population following radiation therapy to extended and limited fields. Int J Radiat Oncol Biol Phys 1979; 5: 1761-1766.
3. 3. Ibery PLT, Rickinson AB, Thrum CE. Blood lymphocyte replicating ability as a measurement of radiation dosage. Br J Radiol 1971; 44: 834-840.
4. 4. Petrini B, Wasserman J, Glas U, Blomgren H. T-lymphocyte subpopulation in blood following radiation therapy for breast cancer. Eur J Cancer Clin Oncol 1982; 18: 921-924.
5. 5. Blomgren H, Baral E, Jarstrand C, Petrini B, Strender LE, Wallgren A, Wasserman J. Effects of external radiation on the peripheral lymphocyte population. In: Dubois JB, Serrou B, Rosenfeld C, eds. Immunopharmacologic effects of radiation therapy. New York: Raven Press; 1981: 299-319.
6. 6. Rotstein S, Blomgren H, Petrini B, Wasserman J, Baral E. Long-term effects on the immune system following local radiation therapy for breast. I. Cellular composition of the peripheral blood lymphocyte population. Int J Radiat Oncol Biol Phys 1985; 11:921-925.
7. 7. Pillai R, Balaram P, Nair BS, Hareendran NK, Padmanabhan TK, Nair MK. Lymphocyte subsets distribution after radiation therapy for cancer of the uterine cervix. Possible prognostic correlation with disease course. Cancer 1991; 67: 2071-2078.
8. 8. Leeper R. Controversies in the treatment of thyroid carcinoma: The New York Memorial Hospital approach. Thyroid Today 1982; 4: 1-6.
9. 131I therapy for metastatic well-differentiated thyroid carcinoma. J Nucl Med 1986; 27: 1519-1527.
10. 131I treatment for nodular goiter. Int J Radiat Oncol Biol Phys 1987; 13: 209-215.
11. 11. Bushnell DL, Boles MA, Kaufman GE, Wadas MA, Barnes WE. Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma. J Nucl Med 1992; 33: 2214-2221.
12. 12. Teng WP, Stark R, Murno AJ, McYoung S, Borysiewicz LK, Weetman AP. Peripheral blood T cell activation after radioiodine treatment for Graves' disease. Acta Endocrinol (Copenh) 1990; 122: 233-240.
13. 13. Maxon MR, Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990; 19: 685-719.
14. 14. Harbert JC. Radioiodine therapy of differentiated thyroid carcinoma. In: Harbert JC, Elckelman WC, Neumann RD, eds. Nuclear medicine: diagnosis and therapy. Stuttgart New York: Thieme; 1996: 975-1019.
15. 15. Tartter PI, Martinelli G, Steinberg B, Barron D. Changes in peripheral T-cell subsets and natural killer cytotoxicity in relation to colorectal cancer surgery. Cancer Detect Prev 1986; 9: 359-364.
16. 16. Uchida A, Kolb R, Micksche M. Generation of suppressor cells for natural killer cell activity in cancer patients after surgery. J Natl Cancer Inst 1982, 68: 735-741.
17. 17. Sedmann PC, Ramsdem CW, Brennan TG, Glies GR, Guillou PJ. Effects of low dose perioperative interferon on the surgically induced suppression of anti-tumour immune response. Br J Surg 1988; 75: 976-981.
18. 18. Nichols PH, Ramsden CW, Ward U, Trejdisiewicz LK, Ambrose NS, Primrose JN. Peri-operative modulation of cellular immunity in patients with colorectal cancer. Clin Exp Immunol 1993, 94: 4-10.
19. 19. Brittenden J, Heys SD, Ross J, Eremin O. Natural killer cells and cancer. Cancer 1996; 77: 1226-1243.
20. 20. Ohashi H, Itoh M. Effects of thyroid hormones on lymphocyte phenotypes in rats: changes in lymphocyte subsets releated to thyroid function. Endocr Regul 1994; 28: 117-123.
21. 21. Corrales JJ, Orfao A, Mirrales JM, San Miguel J. The relationship between hyperthyroidism and the distribution of peripheral blood T, NK and B-lymphocytes in multinodular goiter. Hormon Metab Res 1994; 26: 104-108.
22. 22. Kasuga Y, Kobayashi S, Fujimori M, Shingu K, Asanuma K, Kama Y, Ito K, Maruyama Mamano J. Changes of thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease. Eur J Surg 1998; 164: 173-178.
23. 23. Anderson RE, Williams WL. Radiosensitivity of T and B lymphocytes. Am J Pathol 1977; 89: 367-378.
24. 24. Anderson RE, Warner NL. Ionizing radiation and immune response. Adv Immunol 1976; 24: 215-235.
25. 25. Anderson RE, Lefkovits I, Troup GM. Radiation-induced augmentation of the immune response. Contemp Top Immunobiol 1980; 11: 245-274.
26. 26. De Ruysscher D, Waer M, Vandeputte M, Aerts R, Vantongelen K, van der Schueren E. Changes of lymphocyte subsets after local irradiation for early stage breast cancer and seminoma testis: long-term increase of activated (HLA-DR+) T cells and decrease of "naive" (CD4-CD45R) T lymphocytes. Eur J Cancer 1992; 28: 1729-1734.
27. 27. Talmadge JE, Mejers KM, Prieur DJ, Starkey JR. Role NK cells in tumour growth and metastases in beige mice. Nature 1980; 28: 622-624.
28. 28. Hanna N, Burton RC. Definitive evidence that natural killer (NK) cells inhibit experimental tumour metastases in vivo. J Immunol 1881; 127: 1754-1758.
29. 29. Roder JC, Halitosis T, Klein M, Korec S, Jett J, Ortaldo J, Heberman RB, Kaltz P, Fauci AS. A new immunodeficiency disorder in humans involving NK cells. Nature 1980; 284: 553-555.
30. 30. Sullivan JL, Bryon KS, Brewster FE, Purtilo DT. Deficient natural killer cell activity in X-linked lymphoproliferative syndrome. Science 1980; 210: 543-555.
31. 31. Gui XE, Charles R, Rinaldo JR, Monto HO. Natural killer cell activity in renal transplant recipients receiving cyclosporine. Infect Immun 1983; 41: 965-970.
32. 32. Zeng ZC, Tang ZY, Liu KD, Yu YQ, Yang BH, Cai XJ, Xie H, Cao S. Observation of changes in peripheral T-lymphocyte subsets by flow cytometry in patients with liver cancer treated with radioimmunotherapy. Nucl Med Commun 1995; 16: 378-385.